2003 | Sample Size Calculation for Dichotomous Outcomes in Cluster Randomization Trials with Varying Cluster Size | 강승호 | Article |
2003 | Sample Size Calculation for Dichotomous Outcomes in Cluster Randomization Trials with Varying Cluster Size | 강승호 | Article |
2013 | Strength of Evidence of Non-Inferiority Trials with the Two Confidence Interval Method with Random Margin | 왕소영 | Doctoral Thesis |
2008 | Tests for the homogeneity of two binomial proportions in extremely unbalanced 2 × 2 contingency tables | 강승호 | Article |
2005 | The expected toxicity rate at the maximum tolerated dose in bridging studies in Alzheimer's disease | 강승호 | Article |
2001 | The expected toxicity rate at the maximum tolerated dose in the standard Phase I cancer clinical trial design | 강승호 | Article |
2004 | The size of the chi-square test for the Hardy-Weinberg law | 신동완; 강승호 | Article |
2007 | THE SIZE OF THE COCHRAN-ARMITAGE TREND TEST | 안선영 | Master's Thesis |
2007 | The size of the Cochran-Armitage trend test in 2 × C contingency tables | 강승호 | Article |
2006 | The sizes of the three popular asymptotic tests for testing homogeneity of two binomial proportions | 강승호; 이용희 | Article |
2005 | Urban and rural differences in the prevalence of gender and age specific obesity and related health behaviors in Korea | 강승호 | Article |
2004 | Weighted Random Regression Models and Dropouts | 강승호 | Article |
2004 | Weighted random regression models and dropouts | 강승호 | Article |
2008 | Which exact test is more powerful in testing the hardy-weinberg law? | 강승호 | Article |
2014 | 생물의약품 임상시험에 사용되는 통계학적 고려사항 | 남주선 | Doctoral Thesis |